TY  - GEN
AU  - Miura,Masatomo
AU  - Inoue,Kazuyuki
AU  - Kagaya,Hideaki
AU  - Satoh,Shigeru
AU  - Tada,Hitoshi
AU  - Sagae,Yoshinori
AU  - Habuchi,Tomonori
AU  - Suzuki,Toshio
TI  - Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
SN  - 0142-2782
PY  - 2007///0628
KW  - 2-Pyridinylmethylsulfinylbenzimidazoles
KW  - pharmacology
KW  - Adult
KW  - Area Under Curve
KW  - Aryl Hydrocarbon Hydroxylases
KW  - drug effects
KW  - Cytochrome P-450 CYP2C19
KW  - Cytochrome P-450 CYP3A
KW  - Cytochrome P-450 Enzyme System
KW  - Drug Interactions
KW  - Enzyme Inhibitors
KW  - Female
KW  - Genes, MDR
KW  - Humans
KW  - Immunosuppressive Agents
KW  - blood
KW  - Kidney Transplantation
KW  - Lansoprazole
KW  - Male
KW  - Middle Aged
KW  - Mixed Function Oxygenases
KW  - Polymorphism, Genetic
KW  - Rabeprazole
KW  - Tacrolimus
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/bdd.544
ER  -